Grail's Galleri blood test shows promise in detecting early-stage cancers, boosting the company's stock, but experts call for more data before broad rollout.
Grail's Galleri blood test shows promise in detecting early-stage cancers, boosting the company's stock, but experts call for more data before broad rollout.